ReviewAdvances in therapy2018
Cyclodestructive Procedures in Glaucoma: A Review of Current and Emerging Options.
Review in Advances in therapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
55 citing papers in PubMed.
- Randomized clinical trial for pop titrated versus the slow coagulation cyclophotocoagulation in treating dark irises neovascular glaucoma.Scientific reports · 2025Trial
- EFFICACY OF CYCLOCRYOTHERAPY AND TRANSSCLERAL DIODE LASER CYCLOPHOTOCOAGULATION IN THE MANAGEMENT OF REFRACTORY GLAUCOMA.Acta clinica Croatica · 2021Trial
- The pseudo plateau iris: A review.Indian journal of ophthalmology · 2026Review
- Revisiting the sclera as a target for glaucoma therapy.Eye (London, England) · 2026Review
- Central subfield thickness changes and factors associated with OCT-confirmed cystoid macular edema after slow-coagulation transscleral cyclophotocoagulation for glaucoma.International ophthalmology · 2026Article
- Increased Risk of Intraocular Pressure-Lowering Treatment in Patients with End-Stage Renal Disease Undergoing Hemodialysis.Ophthalmology. Glaucoma · 2026Article
- Juvenile open-angle glaucoma: a clinicopathological update and review.International ophthalmology · 2026Review
- Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma: Two-year Results of a Prospective Multicenter Study.Clinical ophthalmology (Auckland, N.Z.) · 2026Article
- Ultrasonic biomicroscope-guided radiofrequency ablation of the ciliary body in a rabbit glaucoma model.Scientific reports · 2025Article
- The effect of micropulse transcleral cyclophotocoagulation (MP-TSCPC) on anterior segment properties in glaucoma and ocular hypertension patients.International ophthalmology · 2025Article
- Cyclocryotherapy applied at the 3 o'clock and 9 o'clock positions combined with anti-VEGF injections for advanced neovascular glaucoma.International ophthalmology · 2025Article
- Long-Term Treatment Outcomes of Micropulse Transscleral Cyclophotocoagulation in Primary and Secondary Glaucoma: A 5-Year Analysis.Ophthalmology and therapy · 2025Article
- Primary Congenital and Childhood Glaucoma-A Complex Clinical Picture and Surgical Management.Diagnostics (Basel, Switzerland) · 2025Review
- Alterations of the vitreous pathology and anterior chamber angle structures following transscleral cyclophotocoagulation.International journal of ophthalmology · 2025Article
- Efficacy, safety and IOP-lowering mechanisms of ultrasound cycloplasty for angle-closure glaucoma.International journal of ophthalmology · 2025Article
- Current trends and advancements in utilizing endoscopic cyclophotocoagulation for the Treatment of Glaucoma.Lasers in medical science · 2024Review
- Comparison of treatment outcomes between slow coagulation transscleral cyclophotocoagulation and micropulse transscleral laser treatment.Scientific reports · 2024Article
- Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma.Ophthalmology and therapy · 2024Article
- Review
- Outcomes of slow coagulation transscleral cyclophotocoagulation in a predominantly African American glaucoma population.American journal of ophthalmology case reports · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The first surgical modalities to reduce aqueous humor production by damaging the ciliary body date back to the early twentieth century. Until recently, however, cyclodestructive procedures (e.g., cyclocryotherapy and transscleral diode laser photocoagulation) have been reserved as last option procedures in refractory glaucoma patients with poor visual potential. Emerging technologic innovation has led to the development of promising, safer and less destructive techniques, such as micropulse diode cyclophotocoagulation, endoscopic cyclophotocoagulation and ultrasound cyclodestruction. Consequently, an emerging paradigm shift is under way with the selection of these surgical options in eyes with less severe glaucoma and good visual potential. Although existing evidence has not, as yet, adequately defined the role and value of these procedures, their emergence is a welcome expansion of available options for patients with moderate-to-severe glaucoma. This article reviews the pertinent evidence on both established and evolving cyclodestructive techniques and describes their growing role in the management of glaucoma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.